“…Previous studies showed that AFP promoter mutations in the distal HNF1-binding region and the proximal HNF1-binding region play important roles in regulating AFP expression [12,13]. Currently, HNF1A gene variants are associated with maturity onset diabetes of the young (MODY) [14,15], Creactive protein (CRP) levels [16][17][18], gamma-glutamyl transferase (GGT) levels [19,20], total cholesterol (TC) levels [21], pancreatic cancer [22], coronary artery disease [21,23], and metabolic syndrome (MS) [24]. The most common variants in HNF1A are rs1169288 (A/C, Ile27Leu), rs2464196 (G/A, Ser487Asn), and rs1169310 (C/T), which have been reported to be associated with the CRP level, coronary artery disease, and diabetic retinopathy [17,18,25,26].…”